Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat

Go back to Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat
(NASDAQ: TNGX) Delayed: 27.97 -4.32 (13.38%)
Previous Close $32.29    52 Week High
Open $31.10    52 Week Low
Day High $30.34    P/E N/A 
Day Low $27.82    EPS
Volume 12,095,878